← Back to Search

Behavioral Intervention

Digital CRAFT Training for Drug Addiction

N/A
Recruiting
Research Sponsored by We The Village, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be over 19
Be older than 18 years old
Must not have
Is not English-speaking
Does not agree to participate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test the effectiveness of digital training programs for CRAFT at a larger scale and to make them ready for commercial use. The project will involve optimizing the digital training product based on feedback,

Who is the study for?
This trial is for professionals working with families affected by opioid use disorder (OUD). Participants should be interested in learning about the Community Reinforcement and Family Training (CRAFT) approach to maximize treatment rates of OUD.
What is being tested?
The study tests three levels of digital training on CRAFT: a basic tutorial, a tutorial with self-study materials, and a comprehensive package including feedback and coaching. The effectiveness will be measured through knowledge acquisition, fidelity to the method, and impact on treatment entry/retention.
What are the potential side effects?
As this trial involves educational interventions rather than medical treatments or drugs, there are no direct physical side effects expected from participating in the different levels of digital training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 19 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I do not agree to participate in the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CRAFT Procedure Fidelity
Secondary study objectives
3 months
Program Implementation Potential Scale
Other study objectives
New Treatment Entry: Identified Patient Treatment Entry Status

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: TMC - Digital Tutorial plus training Materials plus feedback and CoachingExperimental Treatment3 Interventions
Participants receive the digital tutorial (T) plus the digital Training materials (TM), plus they submit audio recordings of sessions with clients and receive feedback on their application of CRAFT and receive group coaching on how to improve.
Group II: TM - Digital Tutorial plus training MaterialsExperimental Treatment2 Interventions
Participants receive the digital tutorial (T), plus access to 15 additional in depth modules of digital training materials also released weekly alongside the tutorial modules. Modules remain available during the 6-month study timeframe. Participants receive weekly contact encouraging engagement in all of the materials available to them.
Group III: T - Digital Tutorial overviewActive Control1 Intervention
A digital tutorial consisting of a curriculum dashboard for review of 20 modules, including videos, PDFs, text and quizzes, which are to be unlocked sequentially over seven weeks. Modules remain available during the 6-month study timeframe. Participants receive weekly contact encouraging engagement in all of the materials available to them.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,587 Previous Clinical Trials
3,328,308 Total Patients Enrolled
Public Health Management CorporationOTHER
17 Previous Clinical Trials
5,234 Total Patients Enrolled
We The Village, Inc.Lead Sponsor
3 Previous Clinical Trials
304 Total Patients Enrolled
~160 spots leftby Nov 2025